Cite
HARVARD Citation
Hupé, M. et al. (2020). Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study. Alimentary pharmacology & therapeutics. 51 (9), pp. 852-860. [Online].